A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy.
Montagnese S, Lauridsen M, Vilstrup H, Zarantonello L, Lakner G, Fitilev S, Zupanets I, Kozlova I, Bunkova E, Tomasiewicz K, Berglund JE, Rorsman F, Hagström H, Kechagias S, Ocklind CE, Mauney J, Thunarf F, Mokhatarani M, Bäckström T, Doverskog M, Lins LE, Månsson M, Samuelson P, Nilsson D, Schalling M, Johansson M, Arlander E, Scharschmidt BF.
Montagnese S, et al. Among authors: samuelson p.
J Hepatol. 2021 Jul;75(1):98-107. doi: 10.1016/j.jhep.2021.03.012. Epub 2021 Apr 21.
J Hepatol. 2021.
PMID: 33894327
Free article.
Clinical Trial.